Tag: Press Release

Immortal Dragons, a purpose-driven longevity fund headquartered in Singapore, today announced its unique approach to investing in radical life extension technologies. With $40 million in assets under management (AUM), Immortal Dragons is poised to redefine how capital fuels scientific breakthroughs in longevity and healthspan. At its core, Immortal Dragons is driven by a profound philosophy:...

Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter “Chugai”), and Gero PTE. LTD. (hereafter “Gero”), a Singapore-based biotechnology company, announced today that they have entered into a joint research and license agreement to develop novel therapies for age-related diseases. In this collaboration, Chugai will create novel antibody drug candidates using its proprietary antibody engineering technologies for new drug targets...

We are thrilled to announce the second edition of the International Longevity Summit (www.TransVisionMadrid.com) in beautiful Madrid after the major success in 2024. Organized by the Illustrious College of Medical Doctors of Madrid (ICOMEM) and the International Longevity Alliance (ILA), this year we expect over 500 participants with more international experts, including George Church (Professor,...

As China’s population ages rapidly, the development of the longevity industry has been prioritized to the level of national strategy since 2024. To drive its growth, government policies support a broad spectrum of longevity innovations, ranging from preventive wellness to nutritional supplements. Free Trade Zones such as those in Shanghai have been opened to international...

Viva.city and BerlinHouse are opening Viva Frontier Tower, a 6-week popup village in the newly purchased 16-floor Frontier Tower in downtown San Francisco. From June 20 to August 4, this space will bring together people building the future in AI, Crypto, and Longevity. One Tower. Three Tracks. Endless Ideas. For 6 weeks, the tower will...

Scientists have developed a new open source transcriptomic aging clock and published their work as a pre-print [1]. The newly identified rejuvenating drugs and gene perturbations could be applied in regenerative medicine and longevity therapies, and the aging perturbations could find use for anti-cancer therapies. Age-shift learning—one model for every platform Pasta (Predicting age-shift from...